Clinical Trials Logo

Clinical Trial Summary

The high incidence of neurodevelopmental disorders, including specific language and learning disorders, and their profund impact on the schooling of the children concerned remains a major public health concern. Early identification and intervention are a valuable tool for improving these problems. The developmental trajectory of children could be improved by knowledge enhancement, identification and strategies to support the teachers through the involvement of health professionals in the classroom


Clinical Trial Description

PRISME - TSLA is a clinical trial developing experiment project for the intervention arm involving teacher training, the implementation of identification grids, follow-up observations in classroom of identified pupils, and the development of special arrangments. For the control arm, the teachers work with standard procedures of the French national education policy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06062147
Study type Interventional
Source Centre Hospitalier Universitaire de la Réunion
Contact
Status Active, not recruiting
Phase N/A
Start date September 22, 2023
Completion date May 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT05242575 - The Influence of Immersive Virtual Field Trips on Academic Vocabulary N/A
Enrolling by invitation NCT03838016 - Preventing Speech and Language Disorders in Children With Classic Galactosemia N/A
Recruiting NCT06250101 - Training Grammar With Meaning N/A
Active, not recruiting NCT05900180 - Pediatric Speech Therapy Session Frequency and Speech Outcomes N/A
Recruiting NCT05133479 - Let's Know!2: Language-focused Intervention for Children at Risk of Comprehension Difficulties N/A
Completed NCT05487521 - EEG Changes in Pediatrics With Language Dysfunction Evaluation of Sleep EEG Changes in Paediatric Patients With Language Dysfunction: A Follow up Study. EEG Changes in Pediatrics With Language Dysfunction Phase 3